Semaglutide is a GLP-1 receptor agonist that works on your appetite, insulin response, and inflammation pathways
Mounjaro & Ozempic Drug Interactions Taking Ozempic or Mounjaro may interact with certain medications, leading to an increased risk of hypoglycemia and affecting the effectiveness of oral medications due to changes in stomach emptying
Food and Drug Administration is warning patients and health care providers about rising concerns involving unapproved, compounded, and illegally marketed versions of popular GLP-1 weight-loss medications, including semaglutide and tirzepatide
it is encouraged as part of comprehensive weight management
If you're not losing weight on Semaglutide, there could be several reasons why, and understanding these factors is key to achieving your goals
However, a subsequent analysis using a large, nationally representative dataset found no significant association between glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs, including semaglutide, and NAION after controlling for confounding factors
